Health & Medicine
-
Gilead Expands Access For Experimental Coronavirus Drug
Gilead Sciences, Inc, is switching to "expanded access" from a " compassionate use" program to fast track the emergency use of the experimental anti-coronavirus drug, remdesivir for severely ill patients.
Latest Research Articles
-
Microbial DNA in blood may be an indication of cancer - research
-
Surgery Behind 25% Of All U.S. Medical Malpractice Claims
-
Red Eyes: A Telltale Sign of COVID-19?
-
Cardiovascular patients, more vulnerable to COVID-19 - experts
-
COVID-19 Symptom: Loss of Sense of Smell and Taste
-
The Role of Blood Test in the Fight Against the Coronavirus Pandemic
-
Young Adults are Not Invincible to COVID-19, CDC Warns
-
Psychological Impact of Bad Teeth
-
The Race to Find a Cure for the COVID-19 Coronavirus Pandemic
-
COVID-19 Update: Avoid Using Ibuprofen -WHO
-
People with Blood Type A More Prone to COVID-19, Study Says
-
What Happens If You Don't Finish Antibiotics?
MOST POPULAR
-
Why Mother Animals Abandon Their Offspring: The Case of Punch, an Infant Macaque
-
Nanaimoteuthis haggarti: The 62-Foot Giant Prehistoric Octopus That Ruled the Cretaceous Seas
-
How Does Drought Reshape Landscapes and Ecosystems? Stress, Resilience, and Conservation Explained
-
PETA Condemns Viral Baby Monkey Punch's Zoo Conditions As IKEA's Stuffed Orangutan Toy Sells Out
-
Endangered Species 2026: Urgent Global Action Needed Immediately to Save Wildlife at Risk
